Tier 4: Monitoring
Thus beyond lowering glucose (where they can drop A1c roughly 12% as monotherapy or add-on), GLP-1 RAs confer weight loss and cardioprotective benefits a combination particularly advantageous in the many patients with T2D who are overweight or have cardiovascular risk factorsdiabetesonthenet.com
Medical supervision is crucial, particularly when adjusting doses, to ensure that the medications benefits are maximized while keeping side effects manageable
Results from Dihexa can vary depending on the individual, but many patients notice improvements in focus, memory, and overall cognitive function within a few weeks of starting treatment
In the future, a double-blind, randomized, prospective study with a greater sample size may be necessary
It promotes weight loss and improves metabolic indicators, including blood glucose levels and blood pressure